Oxidant stress in the vasculature

Current Atherosclerosis Reports

Volumn 1, Issue 2, 1999, Pages 156-164

  Maytin, Melanie ^a   Leopold, Jane ^a   Loscalzo, Joseph ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arterioscler Thromb Vasc Biol; Nitric Oxide; Probucol; Vascular Smooth Muscle Cell; Xanthine Oxidase

Indexed keywords

ANTIOXIDANT; SUPEROXIDE;

ANIMAL; ARTERIOSCLEROSIS; BLOOD VESSEL; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; BLOOD VESSELS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; RISK FACTORS; SUPEROXIDES; VASCULAR DISEASES; VASOCONSTRICTION; VASODILATION;

EID: 0033187945     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-999-0012-z     Document Type: Article

References (92)

1. Rajagopaian S, Kurz S, Munzel T, et al.: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone. J Clin Invest 1996, 97: 1916–1923.
2. Griendling KK, Wayne AR: Oxidative stress and cardiovascular disease. Circulation 1997, 96: 3264–3265.
3. 2 O2- production in the pig coronary artery. Circulation 1997, 96: 3593–3601.
4. Minor RL, Myer PR, Guerra R, et al.: Diet-induced atherosclerosis increases release of nitrogen oxides from rabbit aorta. J Clin Invest 1990, 86: 2109–2116.
5. Maxwell SR, Lip GYH: Free radicals and antioxidants in cardiovascular disease. Br J Clin Pharmacol 1997, 44: 307–317. DOI: 10.1046/j.1365-2125.1997.t01-1-00594.x
6. Rubin E, Farber JL: Cell Injury. In Pathology. Edited by Rubin E, Farber JL. Philadelphia: Lippincott-Raven; 1999: 1–35.
7. Fantone JC, Ward PA: Inflammation. In Pathology. Edited by Rubin E, Farber JL. Philadelphia: Lippincott-Raven; 1999: 36–75.
8. Darley-Usmar VM, McAndrew J, Patel R, et al.: Nitric oxide, free radicals, and cell signalling in cardiovascular disease. Biochem Soc Trans 1997, 25: 925–929.
9. Houston M, Estevez A, Chumley P, et al.: Binding of xanthine oxidase to vascular endothelium. J Biol Chem 1999, 274: 4985–4994. DOI: 10.1074/jbc.274.8.4985
10. Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993, 91: 2546–2551.
11. Griendling KK, Minieri CA, Ollerenshaw JD, et al.: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994, 74: 1141–1148.
12. DeLeo FR, Ulman KV, Davis AR, et al.: Assembly of the Human Neutrophil NADPH oxidase involves binding of p67phox and flavocytochrome b to a common functional domain in p47phox. J Biol Chem 1996, 271: 17013–17020. DOI: 10.1074/jbc.271.29.17013
13. Vasquez-Vivar J, Martasek P, Hogg N, et al.: Electron spin resonance spin trapping detection of superoxide generated by neuronal nitric oxide synthase. Meth Enzymol 1999, 301: 169–177.
14. Pou S, Keaton L, Surichamorn W, et al.: Mechanism of superoxide generation by neuronal nitric oxide synthase. J Biol Chem 1999, 274: 9573–9580. DOI: 10.1074/jbc.274.14.9573
15. Fridovich I.: Superoxide anion radical (O2-), superoxide dismutases, and related matters. J Biol Chem 1997, 272: 18515–18517. DOI: 10.1074/jbc.272.30.18515
16. Girotti AW: Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998, 39: 1529–1542.
17. Koppenol WH: The basic chemistry of nitrogen monoxide and peroxynitrite. Free Rad Biol Med 1998, 25: 385–391. DOI: 10.1016/S0891-5849(98)00093-8
18. Squadrito GL, Pryor WA: Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Rad Biol Med 1998, 25: 392–403. DOI: 10.1016/S0891-5849(98)00095-1
19. Wink DA, Mitchell JB: Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Rad Biol Med 1998, 25: 434–456. DOI: 10.1016/S0891-5849(98)00092-6
20. Briviba K, Sies H: Nonenzymatic antioxidant defense systems. In Natural Antioxidants in Human Health and Disease. Edited by Frei B. San Diego: Academic Press; 1994: 107–128.
21. Meister A: Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 1994, 269: 9397–9400.
22. Anderson ME: Glutathione and glutathione delivery compounds. In Antioxidants in Disease Mechanisms and Therapy, Advances in Pharmacology. Edited by Sies H. San Diego: Academic Press; 1997: 65–78.
23. Suzuki YJ, Forman HJ, Sevanian A.: Oxidants as stimulators of signal transduction. Free Rad Biol Med 1997, 22: 269–285. DOI: 10.1016/S0891-5849(96)00275-4
24. Liao JK: Endothelium and acute coronary syndromes. Clin Chem 1998, 44: 1799–1808.
25. Gibbons GH, Dzau VJ: Molecular therapies for vascular diseases. Science 1996, 272: 689–693. DOI: 10.1126/science.272.5262.689
26. Bruckdorfer KR: Lipid oxidation products and vascular function. Free Rad Res 1998, 28: 573–581.
27. Tanner FC, Noll G, Boulanger CM, et al.: Oxidized low-density lipoproteins inhibit relaxations of porcine coronary arteries: role of scavenger receptor and endothelium-derived nitric oxide. Circulation 1991, 83: 2012–2020.
28. Munzel T, Sayegh H, Freeman BA, et al.: Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995, 95: 187–194.
29. Ambrosio G, Tritto I, Golino P: Reactive oxygen metabolites and arterial thrombosis. Cardiovasc Res 1997, 34: 445–452. DOI: 10.1016/S0008-6363(97)00101-6
30. Huang PL, Huang Z, Mashimo H, et al.: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377: 239–242. DOI: 10.1038/377239a0
31. Moroi M, Zhang L, Yasuda T, et al.: Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 1998, 101: 1225–1232.
32. Silacci P, Hayoz D: Oxidative stress as the triggering event for vascular remodeling. Nephrol Dial Transplant 1998, 13: 1343–1346.
33. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327: 524–526. DOI: 10.1038/327524a0
34. Harrison DG: Endothelial function and oxidant stress. Clin Cardiol 1997, 20(SII): II-11–II-17.
35. Marui N, Offermann MK, Swerlick R, et al.: Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993, 92: 1866–1874.
36. Collins T, Read MA, Neish AS, et al.: Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995, 9: 899–909.
37. De Caterina R, Libby P, Peng HB, et al.: Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectivity reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995, 96: 60–68.
38. Khan BV, Harrison DG, Olbrych MT, et al.: Nitric oxide regulates vascular cell adhesion molecule-1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA 1996, 93: 9114–9119. DOI: 10.1073/pnas.93.17.9114
39. Spiecker M, Peng HB, Liao JK: Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IκBα. J Biol Chem 1997, 272: 30961–30974. DOI: 10.1074/jbc.272.49.30969
40. Peng HB, Libby P, Liao JK: Induction and stabilization of IκBα by nitric oxide mediated inhibition of NF-kBa. J Biol Chem 1995, 270: 14214–14219. DOI: 10.1074/jbc.270.23.14214
41. Pieper GM, Moore-Hilton G, Roza A: Evaluation of the mechanism of endothelial dysfunction in the genetically diabetic BB rat. Life Sci 1996, 58: 147–152. DOI: 10.1016/0024-3205(95)02360-7
42. Freedman JE, Loscalzo J, Benoit SE, et al.: Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest 1996, 97: 979–987.
43. Welch GN, Upchurch GR, Loscalzo J: Homocysteine, oxidative stress, and vascular disease. Hosp Pract 1997, 32: 81–92.
44. Chin JH, Azhar S, Hoffman BB: Inactivation of endothelium-derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992, 89: 10–18.
45. Loscalzo J: The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996, 98: 5.
46. Upchurch GR Jr., Welch GN, Fabian AJ, et al.: Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997, 272: 17012–17017. DOI: 10.1074/jbc.272.27.17012
47. Howard AB, Alexander RW, Nerem RM, et al.: Cyclic strain induces an oxidative stress in endothelial cells. Am J Physiol (Heart Circ Physiol) 1997, 272: C421–427.
48. Uematsu M, Ohara Y, Navas JP, et al.: Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol (Cell Physiol) 1995, 269: C1371–1378.
49. Nishida K, Harrison DG, Navas JP, et al.: Molecular cloning and characterization of the constituitive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992, 90: 2092–2096.
50. Inove N, Ramasamy S, Fukai T, et al.: Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res 1996, 79: 32–37.
51. Griendling KK, Ushio-Fukai M: Redox control of vascular smooth muscle proliferation. J Lab Clin Med 1998, 132: 9–15. DOI: 10.1016/S0022-2143(98)90019-1
52. Boscoboinik D, Szewceyk A, Hensey C, et al.: Inhibition of cell proliferation by a-tocopherol. Role of protein kinase C. J Biol Chem 1991, 266: 6188–6194.
53. Tsai JC, Jain M, Hsieh C-M, et al.: Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J Biol Chem 1996, 271: 3667–3670. DOI: 10.1074/jbc.271.7.3667
54. Gong KW, Zhu GY, Wang LH, et al.: Effect of active oxygen species on intimal proliferation in rat aorta after arterial injury. J Vasc Res 1996, 33: 42–46.
55. Lafont AM, Chai YC, Cornhill JF, et al.: Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J Clin Invest 1995, 95: 1018–1025.
56. Konneh MK, Rutherford C, Li SR, et al.: Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat. Atherosclerosis 1995, 113: 29–39. DOI: 10.1016/0021-9150(94)05423-G
57. Schnackenberg CG, Welch WJ, Wilcox CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrance-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 1998, 32: 59–64.
58. Kerr S, Brosnan MJ, McIntyre M, et al.: Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 1999, 33: 1353–1358.
59. Di Wang H, Hope S, Du Y, et al.: Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertension 1999, 33: 1225–1232.
60. Heitzer T, Wenzel U, Wenzel U, et al.: Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase. C. Kidney Int 1999, 55: 252–260. DOI: 10.1046/j.1523-1755.1999.00229.x
61. Newez MA, Nawal NN: Effect of alpha-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am J Hypertens 1998, 12: 1480–1485. DOI: 10.1016/S0895-7061(98)00167-8
62. Russo C, Olivieri O, Girelli D, et al.: Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998, 16: 1267–1271. DOI: 10.1097/00004872-199816090-00007
63. Senna SM, Moraes RB, Bravo MF, et al.: Effects of prostaglandins and nitric oxide on rat macrophage lipid metabolism in culture: implications for arterial wall-leukocyte interplay in atherosclerosis. Biochem Mol Biol International 1998, 46: 1007–1018.
64. Chatterjee S: Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol 1998, 18: 1523–1533.
65. Luoma JS, Stralin P, Marklund SL, et al.: Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol 1998, 8: 157–167.
66. Fukai T, Galis ZS, Meng XP, et al.: Vascular expression of extracellular superoxide dismutase in atherosclerosis. J Clin Invest 1998, 101: 2101–2111.
67. Rosenblat M, Aviram M: Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies. Free Rad Biol Med 1998, 24: 305–317. DOI: 10.1016/S0891-5849(97)00231-1
68. Inoue N, Ohara Y, Fukai T, et al.: Probucol improves endothelial-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits. Am J Med Sci 1998, 315: 242–247. DOI: 10.1097/00000441-199804000-00005
69. Kurose I, Wolf RE, Grisham MB, et al.: Hypercholesterolemia enhances oxidant production in mesenteric venules exposed to Ischemia/Reperfusion. Arterioscler Thromb Vasc Biol 1998, 18: 1583–1588.
70. Boger RH, Bode-Boger SM, Phivthong-ngam L, et al.: Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis 1998, 141: 31–43. DOI: 10.1016/S0021-9150(98)00145-2
71. Verhaar MC, Wever RM, Kastelein JJ, et al.: 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 1998, 97: 237–241.
72. Simon E, Paul JL, Atger V, et al.: Erythrocyte antioxidant status in asymptomatic hypercholesterolemic men. Atherosclerosis 1998, 138: 375–381. DOI: 10.1016/S0021-9150(98)00039-2
73. Berliner JA, Territo M, Andalibi A, et al.: Modified lipoproteins and atherosclerosis. In Cellular and Molecular Biology of Atherosclerosis. Edited by Gotto AM. London: Springer-Uerlag; 1992: 77–81.
74. Graier WR, Posch K, Wascher TC, et al.: Role of superoxide anions in changes of endothelial vasoactive response during acute hyperglycemia. Horm Metabol Res 1997, 29: 622–626. DOI: 10.1055/s-2007-979113
75. Ruiz C, Alegria A, Barbera R, et al.: Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Invest 1999, 59: 99–105. DOI: 10.1080/00365519950185823
76. Schleicher ED, Wagner E, Nerlich AG: Increased accumulation of the glycoxidation product N-ε-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 1997, 99: 457–468. DOI: 10.1172/JCI119180
77. Kajanachumpol S, Komindr S, Mahaisiriyodom A: Plasma lipid peroxide and antioxidant levels in diabetic patients. J Med Assoc Thailand 1997, 80: 372–377.
78. Jain SK, Kannan K, Lim G: Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Rad Biol Med 1998, 25: 1083–1088. DOI: 10.1016/S0891-5849(98)00140-3
79. Davi G, Ciabottoni G, Consol A, et al.: In vivo formation of 8-iso-prostaglandin F2α and platelet activation in diabetes mellitus: effects of impaired metabolic control. Circulation 1999; 99: 224–229.
80. Yerneni KK, Bai W, Khan BV, et al.: Hyperglycemia-induced activation of nuclear transcription factor κB in vascular smooth muscle cells. Diabetes 1999, 48: 855–864. DOI: 10.2337/diabetes.48.4.855
81. Su Y, Han W, Giraldo C, et al.: Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1998, 119: 819–825.
82. Gilks CB, Price K, Wright JL, et al.: Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am J Pathol 1998, 152: 269–278.
83. Sugiyama S, Kugiyama K, Ohgushi M, et al.: Supersensitivity of atherosclerotic artery to constrictor effect of cigarette smoke extract. Cardiovas Res 1998, 38: 508–515. DOI: 10.1016/S0008-6363(98)00027-3
84. Keaney JF Jr., Xu A, Cunningham D, et al.: Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest 1995, 95: 2520–2529.
85. Keaney JF Jr., Gaziano JM, Xu A, et al.: Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 1994, 93: 844–851.
86. Cunningham DG, Vita JA, Keaney JF Jr.: Alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL. Clin Res 1994, 42:175A.
87. Diaz MN, Frei B, Vita JA, et al.: Mechanisms of disease: antioxidants and atherosclerotic heart disease. N Engl J Med 1997, 337: 408–416. DOI: 10.1056/NEJM199708073370607
88. Rimm EB, Stampfer MJ, Ascherio A, et al.: Vitamin E consumption and the risk of coronary disease in men. N Engl J Med 1993, 328: 1450–1456. DOI: 10.1056/NEJM199305203282004
89. Stampfer MJ, Hennekens CH, Manson JE, et al.: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993, 328: 1444–1449. DOI: 10.1056/NEJM199305203282003
90. Wallidus G, Erikson U, Olsson AG, et al.: The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol 1994, 74: 875–883. DOI: 10.1016/0002-9149(94)90579-7
91. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994, 330: 1029–1035. DOI: 10.1056/NEJM199404143301501
92. Stephens NG, Parsons A, Schofield PM, et al.: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996, 347: 781–786. DOI: 10.1016/S0140-6736(96)90866-1